We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Boston Scientific (BSX - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Boston Scientific is a member of the Medical sector. This group includes 973 individual stocks and currently holds a Zacks Sector Rank of #8. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Boston Scientific is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BSX's full-year earnings has moved 2.1% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Our latest available data shows that BSX has returned about 18.4% since the start of the calendar year. Meanwhile, stocks in the Medical group have lost about 2.8% on average. This means that Boston Scientific is performing better than its sector in terms of year-to-date returns.
Another stock in the Medical sector, Allarity Therapeutics, Inc. (ALLR - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 28.2%.
Over the past three months, Allarity Therapeutics, Inc.'s consensus EPS estimate for the current year has increased 97.4%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Boston Scientific belongs to the Medical - Products industry, a group that includes 84 individual stocks and currently sits at #96 in the Zacks Industry Rank. Stocks in this group have gained about 7.1% so far this year, so BSX is performing better this group in terms of year-to-date returns.
On the other hand, Allarity Therapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry. This 486-stock industry is currently ranked #99. The industry has moved +2.7% year to date.
Investors interested in the Medical sector may want to keep a close eye on Boston Scientific and Allarity Therapeutics, Inc. as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Boston Scientific (BSX - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Boston Scientific is a member of the Medical sector. This group includes 973 individual stocks and currently holds a Zacks Sector Rank of #8. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Boston Scientific is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BSX's full-year earnings has moved 2.1% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Our latest available data shows that BSX has returned about 18.4% since the start of the calendar year. Meanwhile, stocks in the Medical group have lost about 2.8% on average. This means that Boston Scientific is performing better than its sector in terms of year-to-date returns.
Another stock in the Medical sector, Allarity Therapeutics, Inc. (ALLR - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 28.2%.
Over the past three months, Allarity Therapeutics, Inc.'s consensus EPS estimate for the current year has increased 97.4%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Boston Scientific belongs to the Medical - Products industry, a group that includes 84 individual stocks and currently sits at #96 in the Zacks Industry Rank. Stocks in this group have gained about 7.1% so far this year, so BSX is performing better this group in terms of year-to-date returns.
On the other hand, Allarity Therapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry. This 486-stock industry is currently ranked #99. The industry has moved +2.7% year to date.
Investors interested in the Medical sector may want to keep a close eye on Boston Scientific and Allarity Therapeutics, Inc. as they attempt to continue their solid performance.